843 research outputs found
Varied clinical presentation of Meckel’s diverticulum in pediatric population
Background: Meckel’s diverticulum (MD) is one of the most prevalent congenital abnormalities of the small intestine. Due to its wide-ranging presentations, it often becomes a challenge to diagnose it. Objective: The objective of the study is to analyze varied clinical manifestations of MD in children and their outcomes. Materials and Methods: This was a retrospective study of children diagnosed with MD in the Department of Pediatric Surgery, Medical College of Karnataka from January 2015 to January 2019. A total of 13 patients (10 male and 3 female) aged 1 month–15 years with a diagnosis of MD were included in the study. Their demographic and clinical parameters, investigation, and histopathological findings along with the surgical interventions were collected and analyzed. Results: Patients were presented with varied clinical features such as intestinal obstruction (30.76%), perforated MD (15.38%), diverticulitis (15.38%), gastrointestinal bleed (7.69%), patent vitellointestinal duct (7.69%), and incidental (23.07%). All the cases were investigated and underwent treatment. The most common post-operative complication was wound infection in 2 children which were treated conservatively. Conclusion: A pre-operative diagnosis of complicated MD may be challenging because of the overlapping clinical and imaging features of the other acute surgical and inflammatory conditions of the abdomen. Therefore it is necessary to maintain a high incidence of suspicious in the pediatric age group
The Role of Officer Attributes, Job Characteristics, and Arrest Activity in Explaining Police Use of Force
While numerous studies have examined the causes, correlates, and control of police use of force, many questions remain. This study contributes to the literature on police use of force by examining the role of officers’ background characteristics, job characteristics (patrol area and shift assignment), and arrest activity in explaining variation in the frequency with which officers use force. Analyses were conducted on 1,084 police officers employed in a large municipal police department. Use of force data were obtained from 477 official departmental reports from 2010. Results suggest that a small proportion of officers are responsible for a large proportion of force incidents, and that officers who frequently use force differ in important and significant ways from officers who use force less often (or not at all). Policy implications and directions for future research are discussed
The Physical Hazards of Police Work Revisited
This study examines the extent to which injuries to police officers have changed from 1996-1998 to 2006-2008. Data were obtained from injury reports filed by sworn officers of the Milwaukee (Wisconsin) Police Department. Results indicated that the frequency and rate (injury incidents per officer) of officer assaults, other suspect-related injuries, and accidents declined during the study period. While the specification of the reasons for these changes remains a topic for future research, the decline in assaults and suspect-related injuries may well be a function of the increased availability and more routine use of less lethal technology, enhanced training, and the more common use of protective equipment
Machine learning differentiates enzymatic and non-enzymatic metals in proteins
Metalloenzymes are 40% of all enzymes and can perform all seven classes of enzyme reactions. Because of the physicochemical similarities between the active sites of metalloenzymes and inactive metal binding sites, it is challenging to differentiate between them. Yet distinguishing these two classes is critical for the identification of both native and designed enzymes. Because of similarities between catalytic and non-catalytic metal binding sites, finding physicochemical features that distinguish these two types of metal sites can indicate aspects that are critical to enzyme function. In this work, we develop the largest structural dataset of enzymatic and non-enzymatic metalloprotein sites to date. We then use a decision-tree ensemble machine learning model to classify metals bound to proteins as enzymatic or non-enzymatic with 92.2% precision and 90.1% recall. Our model scores electrostatic and pocket lining features as more important than pocket volume, despite the fact that volume is the most quantitatively different feature between enzyme and non-enzymatic sites. Finally, we find our model has overall better performance in a side-to-side comparison against other methods that differentiate enzymatic from non-enzymatic sequences. We anticipate that our model’s ability to correctly identify which metal sites are responsible for enzymatic activity could enable identification of new enzymatic mechanisms and de novo enzyme design
Management of Elbow Dislocations in the National Football League.
Background: Although much literature exists regarding the treatment and management of elbow dislocations in the general population, little information is available regarding management in the athletic population. Furthermore, no literature is available regarding the postinjury treatment and timing of return to play in the contact or professional athlete.
Purpose: To review the clinical course of elbow dislocations in professional football players and determine the timing of return to full participation.
Study Design: Case series; Level of evidence, 4.
Methods: All National Football League (NFL) athletes with elbow dislocations from 2000 through 2011 who returned to play during the season were identified from the NFL Injury Surveillance System (NFL ISS). Roster position, player activity, use of external bracing, and clinical course were reviewed. Mean number of days lost until full return to play was determined for players with elbow dislocations who returned in the same season.
Results: From 2000 to 2011, a total of 62 elbow dislocations out of 35,324 injuries were recorded (0.17%); 40 (64.5%) dislocations occurred in defensive players, 12 (19.4%) were in offensive players; and 10 (16.1%) were during special teams play. Over half of the injuries (33/62, 53.2%) were sustained while tackling, and 4 (6.5%) patients required surgery. A total of 47 (75.8%) players who sustained this injury were able to return in the same season. For this group, the mean number of days lost in players treated conservatively (45/47) was 25.1 days (median, 23.0 days; range, 0.0-118 days), while that for players treated operatively (2/47) was 46.5 days (median, 46.5 days; range, 29-64 days). Mean return to play based on player position was 25.8 days for defensive players (n = 28; median, 21.5 days; range, 3.0-118 days), 24.1 days for offensive players (n = 11; median, 19 days; range, 2.0-59 days), and 25.6 days for special teams players (n = 8; median, 25.5 days; range, 0-44 days).
Conclusion: Elbow dislocations comprise less than a half of a percent of all injuries sustained in the NFL. Most injuries occur during the act of tackling, with the majority of injured athletes playing a defensive position. Players treated nonoperatively missed a mean of 25.1 days, whereas those managed operatively missed a mean of 46.5 days
Protocol for Rapid Assessment of the Efficacy of Novel Wnt Inhibitors Using Zebrafish Models
Dysregulation of Wnt signaling is a hallmark of many cancers, and the development of effective, non-toxic small-molecule Wnt inhibitors is desirable. Off-target toxicities of new compounds are typically tested in mouse models, which is both costly and time consuming. Here, we present a rapid and inexpensive protocol to determine the in vivo toxicity and efficacy of novel Wnt inhibitors in zebrafish using a combination of a fluorescence reporter assay as well as eye rescue and fin regeneration assays. These experiments are completed within 1 week to rapidly narrow drug candidates before moving to more expensive pre-clinical testing. For complete details on the use and execution of this protocol, please refer to Zhang et al. (2020)
Protein Tyrosine Phosphatase 4A3 (PTP4A3/PRL-3) Drives Migration and Progression of T-Cell Acute Lymphoblastic Leukemia in Vitro and in Vivo
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive blood cancer. There are no immunotherapies and few molecularly targeted therapeutics available for treatment of this malignancy. The identification and characterization of genes and pathways that drive T-ALL progression are critical for the development of new therapies for T-ALL. Here, we determined that the protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3) plays a critical role in T-ALL initiation and progression by promoting leukemia cell migration. PRL-3 is highly expressed in patient T-ALL samples at both the mRNA and protein levels compared to normal lymphocytes. Knock-down of PRL-3 expression using short-hairpin RNA (shRNA) in human T-ALL cell lines significantly impeded T-ALL cell migration capacity in vitro and reduced their ability to engraft and proliferate in vivo in xenograft mouse models. Additionally, PRL-3 overexpression in a Myc-induced zebrafish T-ALL model significantly accelerated disease onset and shortened the time needed for cells to enter blood circulation. Reverse-phase protein array (RPPA) and gene set enrichment analysis (GSEA) revealed that the SRC signaling pathway is affected by PRL-3. Immunoblot analyses validated that manipulation of PRL-3 expression in T-ALL cells affected the SRC signaling pathway, which is directly involved in cell migration, although Src was not a direct substrate of PRL-3. More importantly, T-ALL cell growth and migration were inhibited by small molecule inhibition of PRL-3, suggesting that PRL-3 has potential as a therapeutic target in T-ALL. Taken together, our study identifies PRL-3 as an oncogenic driver in T-ALL both in vitro and in vivo and provides a strong rationale for targeted therapies that interfere with PRL-3 function
Prevention of Renal ApoB Retention is Protective Against Diabetic Nephropathy: Role of TGF-β Inhibition
Animal studies demonstrate that hyperlipidemia and renal lipid accumulation contribute to the pathogenesis of diabetic nephropathy (DN). We previously demonstrated that renal lipoproteins colocalize with biglycan, a renal proteoglycan. The purpose of this study was to determine whether prevention of renal lipid (apoB) accumulation attenuates DN. Biglycan-deficient and biglycan wild-type Ldlr−/− mice were made diabetic via streptozotocin and fed a high cholesterol diet. As biglycan deficiency is associated with elevated transforming growth factor-β (TGF-β), in some experiments mice were injected with either the TGF-β-neutralizing antibody, 1D11, or with 13C4, an irrelevant control antibody. Biglycan deficiency had no significant effect on renal apoB accumulation, but led to modest attenuation of DN with ∼30% reduction in albuminuria; however, biglycan deficiency caused a striking elevation in TGF-β. Use of 1D11 led to sustained suppression of TGF-β for approximately 8 weeks at a time. The 1D11 treatment caused decreased renal apoB accumulation, decreased albuminuria, decreased renal hypertrophy, and improved survival, compared with the 13C4 treatment. Thus, prevention of renal apoB accumulation is protective against development of DN. Furthermore, this study demonstrates that prevention of renal apoB accumulation is a mechanism by which TGF-β inhibition is nephroprotective
- …